NO306700B1 - Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister - Google Patents

Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Info

Publication number
NO306700B1
NO306700B1 NO944214A NO944214A NO306700B1 NO 306700 B1 NO306700 B1 NO 306700B1 NO 944214 A NO944214 A NO 944214A NO 944214 A NO944214 A NO 944214A NO 306700 B1 NO306700 B1 NO 306700B1
Authority
NO
Norway
Prior art keywords
pct
rectal administration
alkylsulfonamides
agonists
pharmaceuticals
Prior art date
Application number
NO944214A
Other languages
English (en)
Norwegian (no)
Other versions
NO944214L (no
NO944214D0 (no
Inventor
Nadine Merlet
Isabelle Richard
Isabelle Thielemans
Original Assignee
Glaxo Lab Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Sa filed Critical Glaxo Lab Sa
Publication of NO944214D0 publication Critical patent/NO944214D0/no
Publication of NO944214L publication Critical patent/NO944214L/no
Publication of NO306700B1 publication Critical patent/NO306700B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
NO944214A 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister NO306700B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929209882A GB9209882D0 (en) 1992-05-07 1992-05-07 Compositions
PCT/EP1993/001077 WO1993021916A1 (en) 1992-05-07 1993-05-03 Pharmaceutical compositions of alkylsulphonamides 5ht1 agonists for rectal administration

Publications (3)

Publication Number Publication Date
NO944214D0 NO944214D0 (no) 1994-11-04
NO944214L NO944214L (no) 1994-11-07
NO306700B1 true NO306700B1 (no) 1999-12-13

Family

ID=10715158

Family Applications (1)

Application Number Title Priority Date Filing Date
NO944214A NO306700B1 (no) 1992-05-07 1994-11-04 Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister

Country Status (33)

Country Link
US (1) US5705506A (bg)
EP (1) EP0639072B1 (bg)
JP (1) JPH07506570A (bg)
KR (1) KR100253111B1 (bg)
AT (1) ATE163850T1 (bg)
AU (1) AU670083B2 (bg)
BE (1) BE1007024A5 (bg)
BG (1) BG62120B1 (bg)
BR (1) BR1100108A (bg)
CA (1) CA2135179C (bg)
CH (1) CH685920A5 (bg)
CY (1) CY2039B1 (bg)
CZ (1) CZ283512B6 (bg)
DE (1) DE69317418T2 (bg)
ES (1) ES2113533T3 (bg)
FR (1) FR2690847B1 (bg)
GB (2) GB9209882D0 (bg)
GR (1) GR3026584T3 (bg)
HK (1) HK95697A (bg)
HU (2) HU227338B1 (bg)
IE (1) IE75203B1 (bg)
IL (1) IL105468A (bg)
IT (1) IT1261471B (bg)
NO (1) NO306700B1 (bg)
NZ (1) NZ252132A (bg)
OA (1) OA10109A (bg)
RO (1) RO112993B1 (bg)
RU (1) RU2118527C1 (bg)
SG (1) SG46649A1 (bg)
TW (1) TW231970B (bg)
UA (1) UA37206C2 (bg)
WO (1) WO1993021916A1 (bg)
ZA (1) ZA933178B (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2434297A (en) * 1996-05-23 1997-12-09 Alcon Laboratories, Inc. The use of 5-ht1b/1d agonists to treat ocular pain
US7189753B1 (en) 1997-11-06 2007-03-13 Cady Roger K Preemptive prophylaxis of migraine
ES2367294T3 (es) * 1998-03-26 2011-11-02 Astellas Pharma Inc. Preparación de liberación sostenida de un compuesto macrólido como tacrolimus.
WO2000051624A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Methods and compositions useful in inhibiting apoptosis
PL2124556T3 (pl) 2006-10-09 2015-02-27 Charleston Laboratories Inc Kompozycje farmaceutyczne
JP5714910B2 (ja) 2008-01-09 2015-05-07 チャールストン ラボラトリーズ，インコーポレイテッド 薬学的組成物
WO2011006012A1 (en) 2009-07-08 2011-01-13 Charleston Laboratories Inc. Pharmaceutical compositions
KR101825972B1 (ko) 2010-10-15 2018-02-06 콘테라 파르마 에이피에스 운동 장애 치료를 위한 세로토닌 수용체 작용제의 조합
US10561618B2 (en) 2012-04-18 2020-02-18 Contera Pharma Aps Orally available pharmaceutical formulation suitable for improved management of movement disorders
JP2019507181A (ja) 2016-03-04 2019-03-14 チャールストン ラボラトリーズ，インコーポレイテッド 医薬組成物
KR102443161B1 (ko) 2016-07-11 2022-09-14 콘테라 파르마 에이/에스 아침 운동 불능을 치료하기 위한 박동성 약물 전달 시스템

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1171450B (it) * 1980-08-12 1987-06-10 Glaxo Group Ltd Composti eterociclici indolici, procedimento per produrli e composizioni farmaceutiche che li contengono
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
GB2082175B (en) * 1980-08-12 1984-05-02 Glaxo Group Ltd Heterocyclic compounds
GR79215B (bg) * 1982-06-07 1984-10-22 Glaxo Group Ltd
GB8332435D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
FR2574077A1 (fr) * 1984-12-04 1986-06-06 Glaxo Group Ltd Derives d'indoles, leur preparation et les compositions pharmaceutiques les contenant
GB8431426D0 (en) * 1984-12-13 1985-01-23 Glaxo Group Ltd Chemical compounds
DE3678805D1 (de) * 1985-11-08 1991-05-23 Glaxo Group Ltd Indolderivate.
PT88255B (pt) * 1987-08-13 1995-03-01 Glaxo Group Ltd Processo para a preparacao de derivados do indole
PT97888B (pt) * 1990-06-07 1998-12-31 Zeneca Ltd Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem

Also Published As

Publication number Publication date
US5705506A (en) 1998-01-06
BG62120B1 (bg) 1999-03-31
BE1007024A5 (fr) 1995-02-21
NZ252132A (en) 1996-09-25
IE75203B1 (en) 1997-08-27
GB2266665A (en) 1993-11-10
FR2690847B1 (fr) 1995-06-09
RO112993B1 (ro) 1998-03-30
ITRM930286A1 (it) 1994-11-06
IT1261471B (it) 1996-05-23
CZ283512B6 (cs) 1998-04-15
NO944214L (no) 1994-11-07
DE69317418D1 (de) 1998-04-16
CY2039B1 (en) 1998-04-30
HUT71418A (en) 1995-11-28
AU670083B2 (en) 1996-07-04
OA10109A (en) 1996-12-18
HU227338B1 (en) 2011-04-28
CA2135179A1 (en) 1993-11-11
BG99167A (bg) 1995-06-30
EP0639072A1 (en) 1995-02-22
SG46649A1 (en) 1998-02-20
FR2690847A1 (fr) 1993-11-12
HU211638A9 (en) 1995-12-28
TW231970B (bg) 1994-10-11
GB9209882D0 (en) 1992-06-24
GR3026584T3 (en) 1998-07-31
RU2118527C1 (ru) 1998-09-10
JPH07506570A (ja) 1995-07-20
EP0639072B1 (en) 1998-03-11
BR1100108A (pt) 1999-12-07
ATE163850T1 (de) 1998-03-15
IE930339A1 (en) 1993-11-17
CA2135179C (en) 2000-12-05
ITRM930286A0 (it) 1993-05-06
WO1993021916A1 (en) 1993-11-11
ES2113533T3 (es) 1998-05-01
CH685920A5 (fr) 1995-11-15
IL105468A0 (en) 1993-08-18
CZ272394A3 (en) 1995-10-18
NO944214D0 (no) 1994-11-04
DE69317418T2 (de) 1998-07-30
UA37206C2 (uk) 2001-05-15
ZA933178B (en) 1994-01-10
GB2266665B (en) 1996-05-22
HK95697A (en) 1997-08-08
AU4064093A (en) 1993-11-29
KR100253111B1 (en) 2000-07-01
IL105468A (en) 1998-09-24
GB9309209D0 (en) 1993-06-16

Similar Documents

Publication Publication Date Title
BR9914526A (pt) Derivados de adenina
DK0641328T3 (da) Broforbundne, azabicykliske derivater som substans P-antagonister
NO20061737L (no) Aminosubstituerte erylamino B2 adrenergiske receptoragonister
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
MX9301032A (es) Compuestos farmaceuticos y procedimento para su preparacion
AP2001002129A0 (en) 5HT1 receptor agonists and metoclopramide for the treatment of migrane.
NO944214L (no) Farmasöytiske preparater for rektal administrering, inneholdende alkylsulfonamider som er HT1-agonister
ES2147758T3 (es) Preparacion sinergistica para la activacion de celulas destructoras naturales.
ZA971279B (en) Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhinitors
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
BR9910329A (pt) Composto, composição farmacêutica, processo para estimular a liberação do hormÈnio de crescimento da pituitária de um mamìfero, e, uso de um composto
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
SE9702002D0 (sv) Novel compounds
TNSN98049A1 (fr) Composition pharmaceutique a residence gastrique.
NO995685L (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasoeytiske blandinger
FI950209A0 (fi) Farmakologisesti aktiiviset alfa-(tertiaarinen-amino-metyyli)-bentseenimetanolijohdannaiset
TW371661B (en) Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides
DE59303446D1 (de) Neue bis-phenyl-hexene
ECSP972347A (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas

Legal Events

Date Code Title Description
MK1K Patent expired